UFD1L Antibody

What is UFD1L and what is its primary cellular function?

UFD1L is an essential component of the ubiquitin-dependent proteolytic pathway that degrades ubiquitin fusion proteins. The ternary complex containing UFD1L, VCP (p97) and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the endoplasmic reticulum (ER) to the cytoplasm, where they are degraded by the proteasome . This complex assists in the extraction of ubiquitinated substrates from membranes and chromatin, ensuring that only properly folded proteins accumulate in cells - a process essential for maintaining cellular function .

Additionally, the NPLOC4-UFD1L-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope . UFD1L also acts as a negative regulator of type I interferon production via the complex formed with VCP and NPLOC4, which binds to RIGI and recruits RNF125 to promote ubiquitination and degradation of RIGI .

Where is UFD1L expressed in tissues and cells?

UFD1L exhibits a specific expression pattern across different tissues. It is predominantly found in adult heart, skeletal muscle, and pancreas . During development, UFD1L expression is detected in fetal liver and kidney tissues , suggesting potential developmental roles in these organs.

At the subcellular level, UFD1L localizes to both the nucleus and cytosol , consistent with its diverse functions in different cellular compartments. This dual localization reflects its roles in both cytoplasmic protein quality control and nuclear processes including spindle disassembly and nuclear envelope formation.

What applications are UFD1L antibodies suitable for in laboratory research?

UFD1L antibodies have been validated for multiple research applications with specific recommended protocols:

When conducting immunofluorescence studies, methanol-fixed cells (such as A431) show clear UFD1L labeling, and co-staining with nuclear markers like Hoechst 33342 helps visualize its subcellular distribution .

How does the UFD1L-VCP-NPLOC4 complex function as an ATP-dependent unfoldase?

The ATPase p97/VCP in complex with its cofactors NPLOC4 and UFD1L functions as a molecular machine that extracts and unfolds ubiquitinated proteins. This unfoldase activity has been directly demonstrated using fluorescence-based assays with model substrates such as ubiquitinated GFP (Ub-GFP) .

The mechanism involves several key steps:

• Recognition of ubiquitinated substrates through the UFD1L-NPLOC4 heterodimer

• ATP-dependent conformational changes in the p97/VCP hexamer

• Physical extraction and unfolding of the target protein

When ubiquitinated GFP is exposed to the p97/VCP- NPLOC4-UFD1L complex in the presence of ATP, the complex unfolds GFP in an ATP-dependent manner, resulting in loss of fluorescence . This process requires the ATPase activity of p97/VCP, as ATP analogs or ATPase inhibitors block the unfolding reaction .

Interestingly, p97 mutations associated with multisystem proteinopathy have been shown to exhibit enhanced unfoldase activity, suggesting that dysregulation of this function may contribute to disease pathology .

What experimental approach can be used to measure UFD1L complex unfoldase activity?

Researchers can quantitatively measure the unfoldase activity of the UFD1L-containing complex using a fluorescence-based assay system. The protocol involves:

• Substrate preparation:

  • Generate ubiquitinated GFP substrates with defined K48-linked ubiquitin chains

  • Options include synthesizing substrates with precise chain lengths (e.g., Ub3Ub-GFP) or creating heterogeneous chains directly on GFP fusion proteins

• Assay components:

  • 25 nM GFP substrate

  • 75 nM p97/VCP hexamer

  • 150 nM adaptor complex (UFD1L-NPLOC4)

  • 250 nM GroEL D87K "trap" (prevents GFP refolding)

  • Assay buffer: 25 mM Hepes pH 7.4, 100 mM KCl, 5 mM MgCl2, 1 mM TCEP, 2 mM ATP

• Measurement conditions:

  • Conduct assays at 37°C

  • Monitor fluorescence using excitation at 488 nm and emission at 509 nm

  • Calculate relative fluorescence by normalizing to time zero values

  • Determine unfolding rates by fitting to exponential decay models

This methodology provides a powerful tool for investigating the mechanistic aspects of UFD1L complex activity and for screening potential modulators of this activity.

How does UFD1L contribute to cell cycle regulation?

UFD1L plays an unexpected but significant role in cell cycle progression, particularly at the G1/S transition. Research has revealed that Ufd1 knockdown leads to:

• Down-regulation of Skp2 (a component of the SCF ubiquitin ligase complex)

• Concomitant up-regulation of p27 (a major substrate of SCF^Skp2)

• Delayed activation of cyclin-dependent kinases CDK1 and CDK2

• Prolonged G1 phase and delayed cell cycle progression

The mechanism involves UFD1L's interaction with the deubiquitinating enzyme USP13, which occurs through amino acids 261-280 of UFD1L . This interaction appears to protect Skp2 from ubiquitination and subsequent degradation. When UFD1L is depleted or when this interaction is disrupted by deletion mutations (Ufd1-Δ261–280), enhanced Skp2 ubiquitination and decreased Skp2 protein levels result .

This regulatory pathway connects UFD1L to the Cdh1-Skp2-p27 axis, revealing a previously unappreciated link between a protein quality control component and cell cycle regulation.

What is the relationship between UFD1L and endoplasmic reticulum stress?

Contrary to what might be expected for a protein involved in ERAD, prolonged ER stress leads to decreased UFD1L expression. When cells are treated with tunicamycin (a glycosylation inhibitor that induces ER stress) for 20 hours, UFD1L protein levels decline concurrent with the accumulation of GRP78/BiP, a canonical marker of the unfolded protein response (UPR) .

This downregulation appears to be part of a regulatory mechanism that connects UFD1L, ER stress, and cell cycle control. Research indicates that G1-arrested cells exhibit facilitated degradation of misfolded proteins, suggesting that the link between UFD1L and cell cycle control may serve to optimize ERAD efficiency during stress conditions .

The dual role of UFD1L in both ERAD and cell cycle regulation may represent an adaptive mechanism that coordinates protein quality control with cell cycle progression during ER stress, potentially preventing the accumulation of misfolded proteins during sensitive phases of the cell cycle.

How does the UFD1L-VCP-NPLOC4 complex specifically recognize ubiquitinated substrates?

The UFD1L complex employs sophisticated recognition mechanisms to identify and process ubiquitinated substrates:

• Ubiquitin chain preference: The complex shows specificity for K48-linked polyubiquitin chains, which are the canonical signal for proteasomal degradation . Studies with model substrates suggest that chains of at least 3-4 ubiquitin molecules are required for efficient recognition, similar to the minimum chain length recognized by the proteasome .

• Substrate binding domains: The UFD1L-NPLOC4 heterodimer functions as the substrate-recruiting component of the complex. UFD1L contains specific regions that recognize ubiquitinated proteins, while VCP/p97 provides the mechanical force for substrate processing .

• Structural recognition: The complex can process substrates with varying ubiquitin chain architectures, including:

  • Defined-length K48-linked chains (e.g., Ub3Ub-GFP)

  • Longer heterogeneous chains built directly onto substrates

  • Branched ubiquitin structures with multiple conjugation points

This recognition flexibility allows the UFD1L complex to handle diverse ubiquitinated substrates encountered in different cellular quality control pathways.

What methodological considerations are important when using UFD1L antibodies?

When working with UFD1L antibodies, researchers should consider several critical factors to ensure experimental success:

Additional considerations:

• Species reactivity: Commercial antibodies have been validated for human samples, with predicted reactivity in mouse and rat based on sequence homology

• Storage conditions: -20°C for long-term stability of antibody reagents

• Validation status: Check if antibodies have been experimentally verified for your specific application and species